I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
MerTK-mediated efferocytosis promotes immune tolerance and ..:
Jinti Lin
;
Ankai Xu
;
Jiakang Jin
...
http://dx.doi.org/10.1080/2162402X.2021.2024941. , 2022
Link:
https://doi.org/10.1080/2162402X.2021.2024941
RT Journal T1
MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:81075e24a2d946e0a51c49d8427bd789&Exemplar=1&LAN=DE A1 Jinti Lin A1 Ankai Xu A1 Jiakang Jin A1 Man Zhang A1 Jianan Lou A1 Chao Qian A1 Jian Zhu A1 Yitian Wang A1 Zhengming Yang A1 Xiumao Li A1 Wei Yu A1 Bing Liu A1 Huimin Tao PB Taylor & Francis Group YR 2022 K1 efferocytosis K1 osteosarcoma K1 mertk K1 pd-l1 K1 m2 polarization K1 immune tolerance K1 Immunologic diseases. Allergy K1 RC581-607 K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://dx.doi.org/10.1080/2162402X.2021.2024941 LK http://dx.doi.org/https://doi.org/10.1080/2162402X.2021.2024941 DO https://doi.org/10.1080/2162402X.2021.2024941 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)